Global Virtual Screening for Drug Discovery Market Growth (Status and Outlook) 2024-2030

Global Virtual Screening for Drug Discovery Market Growth (Status and Outlook) 2024-2030

Virtual screening (VS) is a computational technique used in drug discovery to search libraries of small molecules in order to identify those structures which are most likely to bind to a drug target, typically a protein receptor or enzyme.

The global Virtual Screening for Drug Discovery market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “Virtual Screening for Drug Discovery Industry Forecast” looks at past sales and reviews total world Virtual Screening for Drug Discovery sales in 2022, providing a comprehensive analysis by region and market sector of projected Virtual Screening for Drug Discovery sales for 2023 through 2029. With Virtual Screening for Drug Discovery sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Virtual Screening for Drug Discovery industry.

This Insight Report provides a comprehensive analysis of the global Virtual Screening for Drug Discovery landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Virtual Screening for Drug Discovery portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Virtual Screening for Drug Discovery market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Virtual Screening for Drug Discovery and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Virtual Screening for Drug Discovery.

United States market for Virtual Screening for Drug Discovery is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Virtual Screening for Drug Discovery is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Virtual Screening for Drug Discovery is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Virtual Screening for Drug Discovery players cover MedChemExpress, TargetMol, OpenEye Scientific, Eurofins Discovery, Sygnature Discovery, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Virtual Screening for Drug Discovery market by product type, application, key players and key regions and countries.

Segmentation by Type:
Structure-based Virtual Screening (SBVS)
Ligand-based Virtual Screening (LBVS)
Hybrid Methods

Segmentation by Application:
Pharmaceutical Company
Universities and Research Institutions
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
Structure-based Virtual Screening (SBVS)
Ligand-based Virtual Screening (LBVS)
Hybrid Methods

Segmentation by Application:
Pharmaceutical Company
Universities and Research Institutions
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
MedChemExpress
TargetMol
OpenEye Scientific
Eurofins Discovery
Sygnature Discovery
Jubilant Biosys
Schrödinger, Inc.
Cresset Group
ComputaBio
Profacgen
CD ComputaBio
Creative Biolabs
BOC Sciences
CKTTDB
HitGen
WuXi AppTec
LeadBuilder
CSNpharm
ChemNavigator

Please note: The report will take approximately 2 business days to prepare and deliver.